Compare · ACCD vs MKD
ACCD vs MKD
Side-by-side comparison of Accolade Inc. (ACCD) and Molecular Data Inc. (MKD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ACCD and MKD operate in Business Services (Consumer Discretionary), so they compete in similar markets.
- ACCD is the larger of the two at $1.18B, about 19.0x MKD ($62.0M).
- ACCD has more recent analyst coverage (25 ratings vs 0 for MKD).
- Company
- Accolade Inc.
- Molecular Data Inc.
- Price
- -
- -
- Market cap
- $1.18B
- $62.0M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Business Services
- Business Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- 2019
- News (4w)
- 0
- 0
- Recent ratings
- 25
- 0
Accolade Inc.
Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Molecular Data Inc.
Molecular Data Inc., through its subsidiaries, operates in the chemical e-commerce business in the People's Republic of China. The company operates technology-driven platform that connects participants along the chemical value chain through its integrated solutions. It delivers e-commerce solutions, financial solutions, warehousing and logistics solutions, and software-as-a-service suites for participants in the traditional chemical industry. The company offers its e-commerce solutions through online platform that consists of molbase.com and molbase.cn websites; Moku Data Weixin account; Chemical Community app; and other ancillary platforms. Molecular Data Inc. was founded in 2013 and is headquartered in Shanghai, the People's Republic of China.
Latest ACCD
- Defining Wellness Centers Names Bill Morrison Chief Financial Officer
- SEC Form 15-12G filed by Accolade Inc.
- Amendment: SEC Form SCHEDULE 13D/A filed by Accolade Inc.
- SEC Form 25-NSE filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- Chief Executive Officer Singh Rajeev returned $10,429,525 worth of shares to the company (1,483,574 units at $7.03), closing all direct ownership in the company (SEC Form 4)
Latest MKD
- SEC Form SC 13G filed by Molecular Data Inc.
- SEC Form SC 13G/A filed by Molecular Data Inc. (Amendment)
- SEC Form SC 13G/A filed by Molecular Data Inc. (Amendment)
- SEC Form SC 13G filed by Molecular Data Inc.
- SEC Form 25-NSE filed by Molecular Data Inc.
- 12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session
- Why Express Is Trading Higher By Over 21%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
- Why Cepton Is Trading Higher By 19%; Here Are 28 Stocks Moving Premarket
- SEC Form SC 13G/A filed by Molecular Data Inc. (Amendment)
- 12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session